Levin Tera C, Wickliffe Katherine E, Leppla Stephen H, Moayeri Mahtab
Bacterial Toxins and Therapeutics Section, Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Cell Microbiol. 2008 Dec;10(12):2434-46. doi: 10.1111/j.1462-5822.2008.01220.x. Epub 2008 Aug 28.
Anthrax lethal toxin (LT) rapidly kills macrophages from certain mouse strains in a mechanism dependent on the breakdown of unknown protein(s) by the proteasome, formation of the Nalp1b (NLRP1b) inflammasome and subsequent activation of caspase-1. We report that heat-shocking LT-sensitive macrophages rapidly protects them against cytolysis by inhibiting caspase-1 activation without upstream effects on LT endocytosis or cleavage of the toxin's known cytosolic substrates (mitogen-activated protein kinases). Heat shock protection against LT occurred through a mechanism independent of de novo protein synthesis, HSP90 activity, p38 activation or proteasome inhibition and was downstream of mitogen-activated protein kinase cleavage and degradation of an unknown substrate by the proteasome. The heat shock inhibition of LT-mediated caspase-1 activation was not specific to the Nalp1b (NLRP1b) inflammasome, as heat shock also inhibited Nalp3 (NLRP3) inflammasome-mediated caspase-1 activation in macrophages. We found that heat shock induced pro-caspase-1 association with a large cellular complex that could prevent its activation. Additionally, while heat-shocking recombinant caspase-1 did not affect its activity in vitro, lysates from heat-shocked cells completely inhibited recombinant active caspase-1 activity. Our results suggest that heat shock inhibition of active caspase-1 can occur independently of an inflammasome platform, through a titratable factor present within intact, functioning heat-shocked cells.
炭疽致死毒素(LT)可通过蛋白酶体分解未知蛋白质、形成Nalp1b(NLRP1b)炎性小体并随后激活半胱天冬酶-1的机制,迅速杀死某些小鼠品系的巨噬细胞。我们报告称,对LT敏感的巨噬细胞进行热休克处理可通过抑制半胱天冬酶-1的激活迅速保护它们免受细胞溶解,而对LT的内吞作用或毒素已知的胞质底物(丝裂原活化蛋白激酶)的切割没有上游影响。热休克对LT的保护作用是通过一种独立于从头合成蛋白质、HSP90活性、p38激活或蛋白酶体抑制的机制发生的,并且在丝裂原活化蛋白激酶切割和蛋白酶体对未知底物的降解之后。热休克对LT介导的半胱天冬酶-1激活的抑制并不特异于Nalp1b(NLRP1b)炎性小体,因为热休克也抑制巨噬细胞中Nalp3(NLRP3)炎性小体介导的半胱天冬酶-1激活。我们发现热休克诱导前半胱天冬酶-1与一个大型细胞复合物结合,该复合物可阻止其激活。此外,虽然对重组半胱天冬酶-1进行热休克处理在体外不影响其活性,但热休克细胞的裂解物完全抑制重组活性半胱天冬酶-1的活性。我们的结果表明,热休克对活性半胱天冬酶-1的抑制可通过完整、有功能的热休克细胞中存在的一种可滴定因子独立于炎性小体平台发生。